The link between eye movements and cognitive function in mild to moderate Alzheimer's disease

Xiao-Ting Ma1, Lin-Lin Yao1, Shan-Wen Liu1

  • 1Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, No. 1055, Sanxiang Road, Suzhou, 215004, Jiangsu Province, People's Republic of China.

PubMed

Insights

Eye movement tests reveal cognitive decline in Alzheimer's patients. Saccade task impairments in moderate Alzheimer's disease (AD) correlate with reduced cognitive function, suggesting eye-tracking as a diagnostic tool.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Gerontology

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder impacting cognition.
  • Assessing cognitive function in AD, especially in mild to moderate stages, is crucial for timely intervention.
  • Eye movement analysis offers a potential non-invasive method for cognitive assessment.

Purpose of the Study:

  • To investigate the relationship between eye movement parameters and cognitive function in patients with mild to moderate Alzheimer's disease (AD).
  • To explore the utility of eye-tracking technology in evaluating cognitive domains affected by AD.

Main Methods:

  • Recruited 80 patients with mild to moderate AD and 34 normal controls (NC).
  • Administered neuropsychological tests: Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA).
  • Recorded eye movements using eye-tracking technology during pro-saccade and anti-saccade tasks.

Main Results:

  • Moderate AD patients showed significantly lower accuracy and longer latency in pro-saccade tasks compared to mild AD and NC groups.
  • Moderate AD patients exhibited significantly lower accuracy and error correction rates in anti-saccade tasks.
  • Eye movement metrics, particularly saccade accuracy and latency, correlated significantly with overall cognitive function, orientation, visuospatial skills, and word fluency.

Conclusions:

  • Eye movement parameters, especially in saccade and anti-saccade tasks, are significantly associated with cognitive function in mild to moderate AD.
  • Eye-tracking technology presents a promising, non-invasive tool for cognitive assessment and AD diagnosis/evaluation.